Background Medical research productivity reflects the level
of medical education and practice in a particular country. The objective of
this study was to examine the quantity and quality of medical and biomedical
research published from Palestine.
Findings Comprehensive review of the literature indexed by Scopus was
conducted. Data from Jan 01, 2002 till December 31, 2011 was searched for
authors affiliated with Palestine or Palestinian authority. Results were
refined to limit the search to medical and biomedical subjects. The quality of
publication was assessed using Journal Citation Report. The total number of
publications was 2207. A total of 770 publications were in the medical and
biomedical subject areas. The annual rate of publication was 0.077 articles per
gross domestic product/capita. The 770 publications have an h-index of 32. One
hundred and thirty eight (18%) articles were published in 46 journals that were
not indexed in the web of knowledge. Twenty two (22/770; 2.9%) articles were
published in journals with an IF > 10.
Conclusions The quantity and quality of research originating from Palestinian
institutions is promising given the scarce resources of Palestine. However,
more effort is needed to bridge the gap in medical research productivity and to
promote better health in Palestine.
Aims The main aims of the study were
to investigate the prevalence of pre-diabetes and diabetes mellitus (DM) in
patients with schizophrenia, to compare it with those published in the general
population, and to assess significant associations with dysglycemia defined as
having either pre-DM or DM.
Methods A cross-sectional study carried out
in 4 governmental primary psychiatric healthcare centers in Northern West-Bank,
Palestine. Fasting blood glucose (FBG) and glycated hemoglobin (HbA1c) were
measured. The World Health Organization (WHO) criteria for defining pre-DM and
DM were used. Dysglycemia was defined as FBG >110 mg/dl.
Results Based
on WHO criteria, 27 patients (10.8%) had diabetes and 34 (13.6%) had
pre-diabetes. The prevalence of DM in patients with schizophrenia was not
significantly higher than that reported in the general population of Palestine.
However, the prevalence of pre-DM was significantly higher than that reported
in the general population of Palestine. Regression analysis showed that advancing
age and abnormal waist circumference were significant predictors of dysglycemia
in patients with schizophrenia.
Conclusions This study confirmed the
high prevalence of dysglycemia in patients with schizophrenia, supporting the
need for monitoring of blood glucose in this category of patients. The presence
of primary risk factors is more important in the development of dysglycemia in
patients with schizophrenia than exposure to antipsychotic drugs.
Information about the rate of smoking and factors associated with initiating and maintaining the behaviour is scarce in Palestine. The aim of this study was to explore the rate of and attitudes towards smoking among An-Najah National University students. During spring 2010, a questionnaire adopted from the Global Health Professionals Survey and the Global Youth Tobacco Survey was administered to 954 randomly selected full-time students. Overall 34.7% of the study sample were cigarette or waterpipe smokers, and this rate was higher among males than females (52.7% versus 16.5%). In logistic regression analysis, sex (male), type of college (humanities), older age and higher family income were predictors of current smoking status. Smokers had more negative attitudes to banning smoking in public areas on campus and to education about the harmful effects of smoking. Antismoking programmes with special attention to males and students in humanities are badly needed.
Reports about medication adherence and satisfaction in patients with epilepsy in Arab countries are lacking. The objective of this study was to assess medication adherence and its relationship with treatment satisfaction, number of antiepileptic drugs (AEDs) taken, and epilepsy control in a sample of Palestinian patients.
This cross-sectional descriptive study was carried out at Al-Makhfya Governmental Outpatient Center in Nablus, Palestine, during the summer of 2010. A convenience sampling method was used to select patients over the study period. Medication adherence was measured using the eight-item Morisky Medication Adherence Scale (MMAS); treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Epilepsy was arbitrarily defined as “well controlled” if the patient had had no seizures in the last 3 months and was defined as “poorly controlled” if he or she had had at least one seizure in the last 3 months.
A convenience sample of 75 patients was studied. On the basis of the MMAS, 11 patients (14.7%) had a low rate, 37 (49.3%) had a medium rate, and 27 (36%) had a high rate of adherence. Adherence was positively and significantly correlated with age (P = 0.02) and duration of illness (P = 0.01). No significant difference in adherence was found between patients with well-controlled and those with poorly controlled epilepsy. Similarly, there was no significant difference in adherence between patients on monotherapy and those on polytherapy. Mean satisfaction with respect to effectiveness, side effects, convenience, and global satisfaction were 73.6 ± 20.7, 82.4 ± 29.8, 69.5 ± 15.5, and 68.4 ± 18.3, respectively. There were significant differences in mean values in the effectiveness (P < 0.01) and convenience (P < 0.01) domains, but not the side effect (P = 0.1) and global satisfaction (P = 0.08) domains among patients with different levels of adherence. Patients on monotherapy had significantly higher satisfaction in the effectiveness domain (P = 0.04) than patients on polytherapy. Similarly, patients with well-controlled epilepsy scored significantly higher in the Effectiveness (P = 0.01) and Global Satisfaction (P = 0.01) domains than those with poorly controlled epilepsy.
In our convenience sample, we found that adherence to and satisfaction with AEDs were moderate and were not associated with seizure control or number of AEDs.